Meelis Kadaja is active in the development and commercialization of technologies for biological therapeutics, antibodies, immunoassays and gene therapy. His previous research areas have been DNA viruses and adult tissue specific stem cells. He received MBA and Ph.D in the University of Tartu, Estonia, and completed the postdoctoral training in the Rockefeller University, New York, as a HFSP postdoctoral fellow.
Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October
To sponsor or exhibit contact:
Derek Cavanagh
+44 (0)207 092 1297
derek.cavanagh@terrapinn.com
To speak:
Joan Shutt
+44 (0)207 092 1134
joan.shutt@terrapinn.com